Search research articles
Contact Us
Filters
Showing results (101-110 of 166) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AML
Jatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2002
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia
Francis J Giles, Guillermo Garcia-Manero, Jorge E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors
Jianqing Lin, Jill Gilbert, Michelle A Rudek, et al.
Cancer Research Communications
|
August 22, 2025
Drug-drug interaction liabilities with BTK inhibitor TL-895
Jack C Stromatt, Eman A Ahmed, Thomas Drabison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 10, 2023
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice
Yang Li, Yasuhiro Kazuki, Thomas Drabison, et al.
Journal of the National Cancer Institute
|
April 14, 2011
Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia
Shuiying Hu, Hongmei Niu, Hiroto Inaba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent
Michelle A Rudek, Ming Zhao, Nicola F Smith, et al.
Pharmaceutics
|
September 23, 2022
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities
Yang Li, Yan Jin, Hanieh Taheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Hiroto Inaba, Jolieke G van Oosterwijk, John C Panetta, et al.
Cancer Research Communications
|
March 2, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability
Nadeen Anabtawi, Thomas Drabison, Alexander F Ham, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 166) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AML
Jatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2002
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia
Francis J Giles, Guillermo Garcia-Manero, Jorge E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors
Jianqing Lin, Jill Gilbert, Michelle A Rudek, et al.
Cancer Research Communications
|
August 22, 2025
Drug-drug interaction liabilities with BTK inhibitor TL-895
Jack C Stromatt, Eman A Ahmed, Thomas Drabison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 10, 2023
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice
Yang Li, Yasuhiro Kazuki, Thomas Drabison, et al.
Journal of the National Cancer Institute
|
April 14, 2011
Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia
Shuiying Hu, Hongmei Niu, Hiroto Inaba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent
Michelle A Rudek, Ming Zhao, Nicola F Smith, et al.
Pharmaceutics
|
September 23, 2022
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities
Yang Li, Yan Jin, Hanieh Taheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Hiroto Inaba, Jolieke G van Oosterwijk, John C Panetta, et al.
Cancer Research Communications
|
March 2, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability
Nadeen Anabtawi, Thomas Drabison, Alexander F Ham, et al.
Page
of 17